Nebula Research & Development »

United Therapeutics Corporation shares owned by Nebula Research & Development

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Nebula Research & Development from 13F filings

Historical chart of Nebula Research & Development investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Nebula Research & Development consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Nebula Research & Development

Quarter filed Position value Share count Share price at filing
2023-09-30 $662k 2.9k 225.87

More positions owned by Nebula Research & Development

Intuit (INTU)
Power Integrations (POWI)
Archer Daniels Midland Company (ADM)
Federated Hermes CL B (FHI)
Loews Corporation (L)
Hca Holdings (HCA)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)
Abbott Laboratories (ABT)
Insight Enterprises (NSIT)
S&p Global (SPGI)
Peak (DOC)
Nomad Foods Usd Ord Shs (NOMD)
Union Pacific Corporation (UNP)
Cigna Corp (CI)

View all positions for Nebula Research & Development

Top funds holding United Therapeutics Corporation

Vanguard Group
Wellington Management Company
venBio Select Advisor
Henderson Group
Dimensional Fund Advisors
AQR Capital Management
LSV Asset Management
Bank of New York Mellon
Norges Bank Investment Management
Palo Alto Investors
OrbiMed Advisors
Charles Schwab Investment Management
Pacer Advisors
Nordea Investment Management Ab
Caisse de depot et placement du Quebec

View all funds holding United Therapeutics Corporation